8legs: Hill bw.

#1 out of 1

health17h ago

GLP-1 Drugs May Raise the Risk of Osteoporosis and Gout, Study Suggests

Latest data show GLP-1 users had a higher osteoporosis diagnosis rate than nonusers over five years.
Gout diagnoses were more common among GLP-1 users than nonusers in the study.
Osteomalacia risk also appeared higher among GLP-1 users, 0.2% vs 0.1%.
Researchers caution that the associations do not prove GLP-1s cause these conditions.
Experts note weight loss from GLP-1 therapy might influence bone health, not the drugs alone.
The researchers did not track dosage, adherence, or lifestyle factors in this analysis.
The findings were presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons.
Clinicians are advised to monitor bone health during significant weight loss on GLP-1 therapy.
GLP-1 medications studied include semaglutide drugs Ozempic and Wegovy among others.
The article notes the potential benefit-risk balance of GLP-1 therapies remains, with heart and metabolic benefits often outweighing risks.

Vote 0